$11.19
-0.17 (-1.50%)
Open$11.32
Previous Close$11.36
Day High$11.40
Day Low$11.10
52W High$22.55
52W Low$9.69
Volume—
Avg Volume183.9K
Market Cap225.24M
P/E Ratio—
EPS$-3.70
SectorBiotechnology
Analyst Ratings
Buy
13 analysts
Price Target
+76.1% upside
Current
$11.19
$11.19
Target
$19.70
$19.70
$13.49
$19.70 avg
$20.36
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 131.05M | 4.38M | 103.26M |
| Net Income | 46.72M | -207,966,613 | -15,524,708 |
| Profit Margin | 35.7% | -5,013.7% | -15.0% |
| EBITDA | 37.09M | -245,260,567 | -22,220,211 |
| Free Cash Flow | — | — | -17,331,210 |
| Rev Growth | — | -43.9% | +11.8% |
| Debt/Equity | — | — | 0.46 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $265.21 | +0.28% | 74.0 | 466.74B |
| AMGN | Amgen Inc | $410.24 | +4.34% | 23.7 | 207.25B |
| GILD | Gilead Sciences Inc | $152.67 | +1.40% | — | 187.10B |
| VRTX | Vertex Pharmaceuticals Inc | $514.99 | +0.84% | 29.7 | 130.64B |
| REGN | Regeneron Pharmaceuticals | $803.90 | +0.72% | 18.6 | 80.58B |
| ALNY | Alnylam Pharmaceuticals Inc | $251.65 | +3.00% | 40.0 | 32.33B |